Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Internal Model Harmonisation Approval

14 Sep 2021 14:07

RNS Number : 7533L
Phoenix Group Holdings PLC
14 September 2021
 

LEI: 2138001P49OLAEU33T68

 

Phoenix Group's Internal Model Harmonisation application is approved by the PRA

 

The Board of Phoenix Group Holdings plc ("the Group") is pleased to announce that the Prudential Regulation Authority ("PRA") has approved its application to harmonise its legacy Phoenix and Standard Life internal models.

 

This single, more sophisticated harmonised Internal Model will provide deeper insights into our risk profile which further strengthens the Group's risk management approach and decision making, as well as delivering significant capital synergies through diversification and improved risk modelling.

 

The harmonised Internal Model will go live effective 30 September 2021 and is currently estimated to increase the Group's Solvency II ("SII") Surplus by c.£0.4 billion. It is expected that c.£0.1 billion of the increased SII Surplus will then emerge as an acceleration of cash in 2022, after an appropriate period of operation.

 

The harmonised Internal Model also delivers a reduced capital strain for the Group's Bulk Purchase Annuity ("BPA") new business and unlocks a wider pipeline of future management actions including the execution of Part VIIs, the delivery of further enhancements to the Group's credit risk modelling capabilities and the foundation to bring ReAssure onto the new Internal Model in time. It will also support the Group in delivering future value accretive M&A.

 

-------------------------------------------------------------------------------------------------------------------------------------------------------

Enquiries

Investors/analysts:

Claire Hawkins, Director of Corporate Affairs, Phoenix Group

+44 (0)20 3735 0575

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0)20 3735 0160

Media:

Douglas Campbell, Teneo

+44 (0)775 313 6628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0)20 3735 0922

-------------------------------------------------------------------------------------------------------------------------------------------------------

Legal Disclaimers

This announcement in relation to Phoenix and its subsidiaries (the "Group") contains forward-looking statements about the Group's current plans, goals and expectations relating to future financial events, conditions, performance, results, strategy and/or objectives. Statements containing the words: 'believes', 'intends', 'will', 'expects', 'may', 'should', 'plans', 'aims', 'seeks', 'continues', 'targets' and 'anticipates' or other words of similar meaning are forward-looking. Such forward-looking statements involve risk and uncertainty because they relate to future events and circumstances that are beyond the Group's control. As a result, such future events and the Group's actual future financial condition, performance and results may differ materially from the plans, goals and expectations set out in the forward-looking statements in this announcement. The Group undertakes no obligation to update any of the forward-looking statements contained within this announcement. References in this announcement to Solvency II Surplus should be read in conjunction with the relevant footnotes set out in the 2021 Half Year Results Announcement of 11 August 2021.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAGZGMLFDDGMZM
Date   Source Headline
3rd Jan 20194:15 pmRNSDirector/PDMR Shareholding
31st Dec 20181:00 pmRNSTotal Voting Rights
20th Dec 20182:45 pmRNSHolding(s) in Company
18th Dec 20185:45 pmRNSReduction of Capital
18th Dec 20188:00 amRNSBlock Listing Application
14th Dec 20182:50 pmRNSDirector Declaration
13th Dec 20188:00 amRNSListing of PGH plc Shares and Debt Issuer Update
13th Dec 20187:00 amRNSScheme Effective Date and PGH Shares Cancellation
12th Dec 20182:00 pmRNSListing Application details for New Phoenix Shares
12th Dec 20189:30 amRNSHolding(s) in Company
11th Dec 20189:50 amRNSDirector/PDMR Shareholding
10th Dec 201810:15 amRNSHolding(s) in Company
7th Dec 20184:00 pmRNSDirector/PDMR Shareholding
7th Dec 20187:30 amRNSDirector/PDMR Shareholding
5th Dec 20184:45 pmRNSHolding(s) in Company
5th Dec 20184:11 pmRNSCourt Sanction of Scheme of Arrangement
3rd Dec 20184:30 pmRNSDirector/PDMR Shareholding
3rd Dec 20182:30 pmRNSHolding(s) in Company
30th Nov 20184:00 pmRNSTotal Voting Rights
29th Nov 20187:00 amRNS2018 Trading Update and Capital Markets Day
28th Nov 20183:16 pmRNSCourt and General Meeting Results
23rd Nov 20186:00 pmRNSPhoenix Group Holdings
21st Nov 20188:15 amRNSPhoenix Group Capital Markets Day
14th Nov 201810:00 amRNSHolding(s) in Company
7th Nov 20188:40 amRNSDirector/PDMR Shareholding
7th Nov 20188:40 amRNSDirector/PDMR Shareholding
2nd Nov 20182:15 pmRNSPublication of a Prospectus
2nd Nov 20187:00 amRNSIntroduction of a New Holding Company
31st Oct 20185:00 pmRNSPhoenix Group Holdings Chairman
31st Oct 201812:45 pmRNSTotal Voting Rights
24th Oct 20181:00 pmRNSBlock listing Interim Review
17th Oct 20183:45 pmRNSDirector/PDMR Shareholding
9th Oct 201812:15 pmRNSDirector/PDMR Shareholding
5th Oct 20184:10 pmRNSDirector/PDMR Shareholding
5th Oct 20184:10 pmRNSDirector/PDMR Shareholding
2nd Oct 20184:00 pmRNSHolding(s) in Company
2nd Oct 20189:15 amRNSDirector/PDMR Shareholding
28th Sep 20182:20 pmRNSHolding(s) in Company
28th Sep 20182:20 pmRNSTotal Voting Rights
25th Sep 201812:20 pmRNSHolding(s) in Company
21st Sep 20188:45 amRNSHolding(s) in Company
20th Sep 201812:45 pmRNSPublication of Final Terms
19th Sep 201812:49 pmRNSStabilisation Notic
6th Sep 20184:30 pmRNSDirector/PDMR Shareholding
6th Sep 20188:30 amRNSHolding(s) in Company
6th Sep 20188:30 amRNSHolding(s) in Company
5th Sep 20189:45 amRNSHolding(s) in Company
4th Sep 20184:50 pmRNSHolding(s) in Company
4th Sep 20182:15 pmRNSHolding(s) in Company
3rd Sep 20189:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.